Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Studies of human genetic variation have found strong evidence for the action of natural selection

One of the most comprehensive studies of the forces that have shaped patterns of human genetic variation has found strong evidence for the action of natural selection, which may help explain why certain people are at risk for a variety of conditions and others are not.

8 Sep 2004

Men's magazines don’t inform men about prostate and colon cancer screening

Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men’s magazines.

8 Sep 2004

Study reveals what may be the earliest step in the development of prostate cancer

The finding could open the door to new tests that predict whether the cancer will become aggressive and the development of treatments to prevent the condition from progressing.

2 Sep 2004

Scientists have uncovered a key driver behind the progression of prostate cancer

Scientists at Fred Hutchinson Cancer Research Center have uncovered a key driver behind the progression of prostate cancer, a discovery that the researchers believe could spawn new treatments to prevent the cancer's spread and extend survival.

23 Aug 2004

Dual-action compound shows promise in killing prostate cancer cells

Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

22 Aug 2004

Test for identifying which cases of prostate cancer will become life threatening

Karin Drotschmann, Ph.D., a researcher at Wake Forest University Baptist Medical Center, has won the “New Investigator Award” from the Department of Defense, Prostate Cancer Research Program, for her work to develop a test for identifying which cases of prostate cancer will become life threatening.

20 Aug 2004

Combination therapies improve prostate cancer survival rates

The addition of six months of androgen suppression therapy (AST) to radiation therapy improves survival of patients with clinically localized prostate cancer, according to a study in the current issue of the Journal of the American Medical Association.

18 Aug 2004

New blood test to detect ovarian cancer

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

16 Aug 2004

Blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

15 Aug 2004

Possible role for BK virus in development of prostate cancer

Now, new research by scientists at the University of Michigan Medical School suggests the intriguing possibility that this common virus also may play a role in prostate cancer – the second-leading cause of deaths from cancer in American men.

9 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

Moderate exercise helps beat fatigue from prostate radiation

Men who get a moderate amount of exercise during radiation for prostate cancer are better able to cope with the fatigue the treatment can cause, researchers from Scotland report in the journal Cancer.

5 Aug 2004

Free prostate screening days for men in the Washington DC area

The Lombardi Comprehensive Cancer Center and the Department of Urology at Georgetown University Hospital are offering their tenth annual free prostate screening days for local area men.

3 Aug 2004

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.

2 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Further evidence about how estrogen helps activate breast cancer

A UC Irvine researcher has found a novel tumor- suppressor function for a gene that, when mutated, often triggers breast cancer in women.

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Studies of human genetic variation have found strong evidence for the action of natural selection

Men's magazines don’t inform men about prostate and colon cancer screening

Study reveals what may be the earliest step in the development of prostate cancer

Scientists have uncovered a key driver behind the progression of prostate cancer

Dual-action compound shows promise in killing prostate cancer cells

Test for identifying which cases of prostate cancer will become life threatening

Combination therapies improve prostate cancer survival rates

New blood test to detect ovarian cancer

Blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease

Possible role for BK virus in development of prostate cancer

Australian university signs multi-million dollar anti-cancer research deal

Moderate exercise helps beat fatigue from prostate radiation

Free prostate screening days for men in the Washington DC area

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

New approach to cancer vaccines may eradicate skin cancer tumors

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Further evidence about how estrogen helps activate breast cancer

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in